Use of the drug Soliris (eculizumab) effectively treated atypical hemolytic uremic syndrome (aHUS) in a pregnant woman in…
Articles by Andrea Lobo
Soliris (eculizumab) was used to effectively treat atypical hemolytic uremic syndrome (aHUS) in a young woman with systemic…
A woman in her early 30s who developed pregnancy-associated atypical hemolytic-uremic syndrome (aHUS) after the birth of her baby…
Colombian children seen for the first time for atypical hemolytic uremic syndrome (aHUS) had a high frequency of disease…
An 8-year-old girl was diagnosed with a rare case of atypical hemolytic uremic syndrome (aHUS) and cardiac arrhythmias, or abnormal…
A mutation in the complement factor I (CFI) gene can lead in rare cases to both atypical hemolytic uremic…
Both Soliris (eculizumab) and Ultomiris (ravulizumab) are safe, and have similar effectiveness in improving kidney function and blood…
A group of blood disorders called hypereosinophilia syndrome, known as HES, was suspected to be the trigger event that led…
Short-term use of Soliris (eculizumab) successfully treated atypical hemolytic uremic syndrome (aHUS) that had no genetic link in…
Reduced capillary density and capillary abnormalities were identified in people with atypical hemolytic uremic syndrome (aHUS) using a nailfold…